FGF21 and obesity disorder: An intriguing possibility is that a chronic release of this molecule in the obesity status could lead to an S100A4 resistant situation, in a similar way to what has been shown for other molecules including leptin and FGF21.27, 28 Further studies are warranted to determine the occurrence of an S100A4 resistant state in obesity.